April 27, 2020 / 12:31 PM / a month ago

BRIEF-Sutro Biopharma Had Cash, Cash Equivalents And Marketable Securities Of About $129.6 Mln As Of March 31

April 27 (Reuters) - Sutro Biopharma Inc:

* SUTRO BIOPHARMA INC - HAD CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF ABOUT $129.6 MILLION AS OF MARCH 31, 2020 Source: (bit.ly/3bM6D2E) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below